296 related articles for article (PubMed ID: 12482341)
21. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
[TBL] [Abstract][Full Text] [Related]
22. [Apoptosis and proliferation of CD34 positive bone marrow cells in patients with polycythemia vera].
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Tu MF; Cui ZZ; Jia HR; Sun J; Qian LS; Yang TY; Yang CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):195-7. PubMed ID: 15182553
[TBL] [Abstract][Full Text] [Related]
23. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hemostatic balance in blood from patients with polycythemia vera by means of thromboelastography: the effect of isovolemic erythrocytapheresis.
Rusak T; Ciborowski M; Uchimiak-Owieczko A; Piszcz J; Radziwon P; Tomasiak M
Platelets; 2012; 23(6):455-62. PubMed ID: 22098131
[TBL] [Abstract][Full Text] [Related]
25. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
Kvasnicka HM; Thiele J
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
[TBL] [Abstract][Full Text] [Related]
26. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis.
Passamonti F; Rumi E; Caramella M; Elena C; Arcaini L; Boveri E; Del Curto C; Pietra D; Vanelli L; Bernasconi P; Pascutto C; Cazzola M; Morra E; Lazzarino M
Blood; 2008 Apr; 111(7):3383-7. PubMed ID: 18187660
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 438 patients with essential thrombocythemia].
Lan HF; Fang ZH; Zhang Y; Wang XY; Xue F; Zhang L; Guo ZX; Dong XW; Li SZ; Zheng YZ; Zhang FK; Qian LS; Ji LX; Xiao ZJ; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):587-91. PubMed ID: 19175983
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
Corre-Buscail I; Pineau D; Boissinot M; Hermouet S
Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414
[TBL] [Abstract][Full Text] [Related]
29. An inhibitor of Janus kinase 2 prevents polycythemia in mice.
Mathur A; Mo JR; Kraus M; O'Hare E; Sinclair P; Young J; Zhao S; Wang Y; Kopinja J; Qu X; Reilly J; Walker D; Xu L; Aleksandrowicz D; Marshall G; Scott ML; Kohl NE; Bachman E
Biochem Pharmacol; 2009 Aug; 78(4):382-9. PubMed ID: 19413997
[TBL] [Abstract][Full Text] [Related]
30. Polycythemia and oxygen sensing.
Maran J; Prchal J
Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of red cell distribution width in polycythemia vera].
Yonemitsu H; Kodama A; Sakuma H; Oyama M; Shimada T; Tabata Y
Rinsho Byori; 1989 Jul; 37(7):813-8. PubMed ID: 2607651
[TBL] [Abstract][Full Text] [Related]
32. Biological and radiological investigations in patients with an increased red blood cell mass: Which are needed? Which are useful? which are unnecessary?
Delannoy A
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):159-63. PubMed ID: 8036133
[TBL] [Abstract][Full Text] [Related]
33. Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients.
Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Saumell S; Salar A; Abella E; Gimeno E; Serrano S; Florensa L; Sánchez B; Pedro C; Besses C
Br J Haematol; 2009 Sep; 146(5):504-9. PubMed ID: 19604233
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and therapy of polycythemia vera.
Lengfelder E; Merx K; Hehlmann R
Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
[TBL] [Abstract][Full Text] [Related]
35. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
Takeyama H; Shimokawa T; Yamada H; Watanabe E
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2833-7. PubMed ID: 7993124
[TBL] [Abstract][Full Text] [Related]
36. Plasma homocysteine levels in 10 patients with polycythemia.
Tonon G; Boyd K; Lecchi A; Lombardi R; Porcella A; Cattaneo M
Haematologica; 1997; 82(3):343-4. PubMed ID: 9234587
[TBL] [Abstract][Full Text] [Related]
37. Influence of the assays of endogenous colony formation and serum erythropoietin on the diagnosis of polycythemia vera and essential thrombocythemia.
Mossuz P;
Semin Thromb Hemost; 2006 Apr; 32(3):246-50. PubMed ID: 16673278
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of a one step sandwich enzymeimmunoassay for serum erythropoietin--serum erythropoietin values in polycythemia vera and related hematological disorders].
Sawabe Y; Iida S; Tabata Y; Yonemitsu H
Rinsho Byori; 1993 Jan; 41(1):75-82. PubMed ID: 8355412
[TBL] [Abstract][Full Text] [Related]
39. Inapparent polycythemia vera: an unrecognized diagnosis.
Lamy T; Devillers A; Bernard M; Moisan A; Grulois I; Drenou B; Amiot L; Fauchet R; Le Prise PY
Am J Med; 1997 Jan; 102(1):14-20. PubMed ID: 9209196
[TBL] [Abstract][Full Text] [Related]
40. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
